Cargando…
Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma
Excision repair cross-complementation group 6 like (ERCC6L) has been reported to be upregulated in a variety of malignant tumors and plays a critical oncogenic role. However, the role and molecular mechanism of ERCC6L in lung adenocarcinoma (LUAD) remain unclear, and were therefore investigated in t...
Autores principales: | Huang, Xiaoyue, Jiang, Lingyu, Lu, Sufang, Yuan, Mingqing, Lin, Hui, Li, Baijun, Wen, Zhaoke, Zhong, Yonglong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204608/ https://www.ncbi.nlm.nih.gov/pubmed/35656882 http://dx.doi.org/10.3892/or.2022.8342 |
Ejemplares similares
-
Knockdown of TTC9 inhibits the proliferation, migration and invasion, but induces the apoptosis of lung adenocarcinoma cells
por: Huang, Xiaoyue, et al.
Publicado: (2022) -
Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
por: Zhong, Yonglong, et al.
Publicado: (2015) -
Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer
por: Wang, Shujie, et al.
Publicado: (2021) -
Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
por: Guo, Geng, et al.
Publicado: (2015) -
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma
por: Chen, Rui, et al.
Publicado: (2023)